Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Capstone Therapeutics Corp

+ Add to Watchlist

CAPS:US

0.1550 USD 0.00000.00%

As of 09:47:38 ET on 05/27/2015.

Snapshot for Capstone Therapeutics Corp (CAPS)

Open: 0.1550 Day's Range: 0.1550 - 0.1550 Volume: 1,400
Previous Close: 0.1550 52wk Range: 0.1500 - 0.3900 1-Yr Rtn: -38.00%

Stock Chart for CAPS

No chart data available.
  • CAPS:US 0.1550
  • 1D
  • 1M
  • 1Y
0.1550
Interactive CAPS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CAPS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 6.34
Shares Outstanding (M) 40.89
30 Day Average Volume 14,928
Price/Book (mrq) 2.0423
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CAPS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CAPS

Capstone Therapeutics Corporation is a biotechnology company that develops therapeutic peptides. The Company researches treatments for pulmonary disease, prevention of hypertrophic and keloid scarring and intimal hyperplasia, and cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues.

John M Holliman III "Jock"Chairman/CEOLeslie M TaegerSenior VP/CFO
More Company Profile & Key Executives for CAPS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil